{"id":"hyperpolarized-xenon","safety":{"commonSideEffects":[{"rate":null,"effect":"Minimal adverse events reported; xenon is inert and non-toxic"}]},"_chembl":{"chemblId":"CHEMBL4594411","moleculeType":"Small molecule","molecularWeight":"128.90"},"_dailymed":{"setId":"70e33fe3-c722-439b-b3db-c2a22f229c8a","title":"XENOVIEW (XENON XE 129 HYPERPOLARIZED) GAS [POLAREAN, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Xenon-129 is hyperpolarized through optical pumping to achieve non-equilibrium spin alignment, dramatically increasing its MRI sensitivity compared to conventional imaging. When inhaled, the hyperpolarized xenon distributes throughout the lungs and can cross the alveolar-capillary membrane into red blood cells and tissue, providing detailed anatomical and functional information about pulmonary ventilation and gas exchange. This enables visualization of regional lung function without ionizing radiation.","oneSentence":"Hyperpolarized xenon is inhaled as a contrast agent that enhances magnetic resonance imaging (MRI) by providing increased signal in lung tissue due to its nuclear spin polarization.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:34:25.160Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pulmonary ventilation imaging in patients with chronic obstructive pulmonary disease (COPD)"},{"name":"Assessment of regional lung function and gas exchange abnormalities"}]},"trialDetails":[{"nctId":"NCT06856525","phase":"PHASE2, PHASE3","title":"Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology","status":"RECRUITING","sponsor":"Y. Michael Shim, MD","startDate":"2024-12-19","conditions":"Electronic Cigarette Related Lung Damage","enrollment":80},{"nctId":"NCT04977830","phase":"NA","title":"Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients","status":"WITHDRAWN","sponsor":"Patrick Cahill, MD","startDate":"2026-01","conditions":"Thoracic Insufficiency Syndrome","enrollment":""},{"nctId":"NCT02740868","phase":"PHASE2","title":"Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease","status":"RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2015-08","conditions":"Cystic Fibrosis, Asthma","enrollment":30},{"nctId":"NCT06104228","phase":"PHASE2","title":"129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-08-12","conditions":"Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)","enrollment":20},{"nctId":"NCT04778046","phase":"PHASE2","title":"Pulmonary Hypertension SOLAR","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2023-11-08","conditions":"Interstitial Lung Disease, COPD, Pulmonary Arterial Hypertension","enrollment":30},{"nctId":"NCT05241275","phase":"PHASE2","title":"Xenon MRI and Progressive ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2022-07-19","conditions":"Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis","enrollment":60},{"nctId":"NCT06351345","phase":"PHASE2","title":"129 Xenon Imaging in Patients Treated With Sotatercept","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-10-27","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":14},{"nctId":"NCT02272049","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-12","conditions":"Respiratory Disorders","enrollment":300},{"nctId":"NCT06012500","phase":"PHASE1, PHASE2","title":"Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-04-14","conditions":"ILD","enrollment":78},{"nctId":"NCT05041140","phase":"","title":"Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-08-14","conditions":"Pulmonary, Pneumonia, Hematopoietic System--Cancer","enrollment":25},{"nctId":"NCT04035629","phase":"PHASE1","title":"129Xe MRI in Pediatric Population With BPD","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2026-08-01","conditions":"Bronchopulmonary Dysplasia","enrollment":""},{"nctId":"NCT06038630","phase":"PHASE2","title":"129Xe MRI Cardiopulmonary","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-01-12","conditions":"Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism","enrollment":125},{"nctId":"NCT04467957","phase":"PHASE4","title":"Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-11-15","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT07355231","phase":"PHASE1, PHASE2","title":"Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI","status":"NOT_YET_RECRUITING","sponsor":"Xemed LLC","startDate":"2026-03-01","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":10},{"nctId":"NCT05302817","phase":"PHASE1","title":"Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2023-03-17","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":9},{"nctId":"NCT05816616","phase":"","title":"Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2025-09-01","conditions":"COPD","enrollment":""},{"nctId":"NCT04995562","phase":"PHASE4","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Infants","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-05-06","conditions":"Lungs; Developmental Disorder","enrollment":12},{"nctId":"NCT04259970","phase":"PHASE4","title":"Hyperpolarized Imaging for New Treatments","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-01-13","conditions":"Cystic Fibrosis","enrollment":64},{"nctId":"NCT04071769","phase":"PHASE2","title":"Genentech Xenon MRI Idiopathic Pulmonary Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-08-03","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":34},{"nctId":"NCT05914506","phase":"","title":"Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2023-10-05","conditions":"Progressive Fibrosing Interstitial Lung Disease","enrollment":30},{"nctId":"NCT02220426","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-09-01","conditions":"Obesity","enrollment":17},{"nctId":"NCT07139899","phase":"","title":"Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-11-17","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT04991454","phase":"PHASE2","title":"Xenon MRI Pulm Hypertension","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2021-09-01","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":60},{"nctId":"NCT03603899","phase":"PHASE1, PHASE2","title":"Hp129 Xenon Imaging and BOS in Lung Transplantation","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-09-09","conditions":"Bronchiolitis Obliterans","enrollment":3},{"nctId":"NCT04941573","phase":"","title":"Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2021-01-19","conditions":"Lung Transplant Rejection","enrollment":45},{"nctId":"NCT05433961","phase":"PHASE1","title":"Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2023-10-20","conditions":"COPD","enrollment":27},{"nctId":"NCT07174713","phase":"NA","title":"REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2025-10","conditions":"Asthma; Eosinophilic","enrollment":200},{"nctId":"NCT02316379","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-02","conditions":"Respiratory Disorders","enrollment":100},{"nctId":"NCT05550662","phase":"PHASE2","title":"HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2024-02-07","conditions":"Lung Transplant Rejection","enrollment":6},{"nctId":"NCT04726618","phase":"","title":"Development of Hardware and Software for Pulmonary Magnetic Resonance Imaging Using Inhaled Tracer Gases","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2022-03-01","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT02723474","phase":"NA","title":"A Single-Centre Pilot Study Exploring the Utility of Magnetic Resonance Imaging in Patients With Chronic Lung Disease","status":"COMPLETED","sponsor":"Western University, Canada","startDate":"2007-11","conditions":"Lung Disease","enrollment":66},{"nctId":"NCT03733535","phase":"NA","title":"Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2022-03-01","conditions":"Asthma; Eosinophilic","enrollment":29},{"nctId":"NCT03431129","phase":"","title":"Hyperpolarized 129Xe Magnetic Resonance Imaging for Evaluation of Radiation-Induced Lung Injury in Subjects Undergoing Thoracic Irradiation","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2018-09-01","conditions":"Radiation Induced Lung Injury (RILI)","enrollment":1},{"nctId":"NCT03475264","phase":"","title":"MRI of Lung Structure and Function in Preterm Children","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2018-09-01","conditions":"Bronchopulmonary Dysplasia","enrollment":12},{"nctId":"NCT02912637","phase":"","title":"Hyperpolarized Xenon Imaging in Patients With Cystic Fibrosis","status":"WITHDRAWN","sponsor":"Papworth Hospital NHS Foundation Trust","startDate":"2016-10","conditions":"Cystic Fibrosis","enrollment":""},{"nctId":"NCT06985225","phase":"","title":"Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2025-06","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT04624490","phase":"PHASE1","title":"Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease","status":"RECRUITING","sponsor":"Mario Castro, MD, MPH","startDate":"2020-11-02","conditions":"Asthma, COPD, Interstitial Lung Disease","enrollment":260},{"nctId":"NCT04659707","phase":"PHASE1","title":"Hyperpolarized 129Xe MRI of Survivors of COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2021-02-22","conditions":"Covid19","enrollment":20},{"nctId":"NCT05766384","phase":"","title":"Hyperpolarized 129Xe MRI Lung Health Cohort","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-11-30","conditions":"Healthy","enrollment":260},{"nctId":"NCT05339386","phase":"","title":"Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-08-29","conditions":"Pulmonary Arterial Hypertension","enrollment":10},{"nctId":"NCT04793867","phase":"","title":"Regional Phenotyping of CF and Non-CF Bronchiectasis","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-02-08","conditions":"Cystic Fibrosis, Non-CF Bronchiectasis","enrollment":100},{"nctId":"NCT06819969","phase":"","title":"The Canadian Lung Outcomes in Users of Vaping Devices Study","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2025-02","conditions":"Small Airways Diseases, Vaping, Vaping Related Disorder","enrollment":500},{"nctId":"NCT02848560","phase":"","title":"Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2016-03","conditions":"Cystic Fibrosis","enrollment":38},{"nctId":"NCT04761393","phase":"","title":"Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-11-29","conditions":"Emphysema","enrollment":45},{"nctId":"NCT02638519","phase":"EARLY_PHASE1","title":"HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-06-27","conditions":"Alzheimer Disease","enrollment":51},{"nctId":"NCT02748798","phase":"EARLY_PHASE1","title":"Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2020-11-10","conditions":"Lung Transplant, Lung Resection, Lung Cancer","enrollment":10},{"nctId":"NCT02484885","phase":"NA","title":"Xenon-129 Magnetic Resonance Imaging of Healthy Subjects: Hardware and Software Development and Reproducibility","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2011-08","conditions":"Healthy Volunteers","enrollment":50},{"nctId":"NCT02723500","phase":"NA","title":"129 Xenon MRI in Chronic Lung Disease","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2011-08","conditions":"Lung Disease","enrollment":100},{"nctId":"NCT04828135","phase":"PHASE2","title":"Dual MRI for Cardiopulmonary COVID-19 Long Haulers","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2021-05-26","conditions":"Covid19","enrollment":18},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT06122922","phase":"PHASE2","title":"Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)","status":"WITHDRAWN","sponsor":"Bastiaan Driehuys","startDate":"2024-03-15","conditions":"Pulmonary Artery Hypertension","enrollment":""},{"nctId":"NCT04858191","phase":"","title":"Utilizing Hyperpolarized 129Xe Magnetic Resonance Imaging in Children With Primary Ciliary Dyskinesia","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2021-09-01","conditions":"Primary Ciliary Dyskinesia","enrollment":16},{"nctId":"NCT03632369","phase":"","title":"Hyperpolarized Noble Gas MRI Detection of Radiation-Induced Lung Injury","status":"WITHDRAWN","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-12","conditions":"Radiation Induced Lung Injury, Non Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT02151604","phase":"PHASE2","title":"Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2014-04-23","conditions":"Non-small Cell Lung Cancer","enrollment":22},{"nctId":"NCT02478255","phase":"PHASE2","title":"Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2016-03-21","conditions":"Radiation Injury","enrollment":25},{"nctId":"NCT04677426","phase":"PHASE2","title":"129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis","enrollment":""},{"nctId":"NCT03417687","phase":"PHASE3","title":"Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection","status":"COMPLETED","sponsor":"Polarean, Inc.","startDate":"2018-08-17","conditions":"Pulmonary Surgical Procedures","enrollment":38},{"nctId":"NCT03593434","phase":"","title":"Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-07-30","conditions":"Cystic Fibrosis","enrollment":20},{"nctId":"NCT02112929","phase":"PHASE1","title":"Regional Lung Imaging Using Hyperpolarized Xenon Gas","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2012-04","conditions":"Lung Disease","enrollment":17},{"nctId":"NCT02478268","phase":"PHASE1","title":"Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2015-05","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":64},{"nctId":"NCT03482960","phase":"EARLY_PHASE1","title":"Comparison of 129Xe MRI With 19F MRI in CF Lung Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-05-29","conditions":"Cystic Fibrosis","enrollment":11},{"nctId":"NCT04662658","phase":"PHASE1, PHASE2","title":"Hyperpolarized Xenon-129 MR Imaging of the Lung","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2020-11-05","conditions":"E-Cig Use","enrollment":24},{"nctId":"NCT02826343","phase":"EARLY_PHASE1","title":"New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2016-05-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":30},{"nctId":"NCT03418090","phase":"PHASE3","title":"Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant","status":"COMPLETED","sponsor":"Polarean, Inc.","startDate":"2018-08-17","conditions":"Pulmonary Surgical Procedures","enrollment":48},{"nctId":"NCT01832363","phase":"PHASE2, PHASE3","title":"Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI","status":"COMPLETED","sponsor":"Xemed LLC","startDate":"2013-03","conditions":"Asthma","enrollment":30},{"nctId":"NCT03764163","phase":"EARLY_PHASE1","title":"Image and Model Based Analysis of Lung Disease","status":"COMPLETED","sponsor":"Eric A. Hoffman","startDate":"1997-09-30","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":341},{"nctId":"NCT02606487","phase":"","title":"Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary Exacerbations","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2015-11","conditions":"Cystic Fibrosis","enrollment":21},{"nctId":"NCT01697332","phase":"PHASE1, PHASE2","title":"Functional Applications of Hyperpolarized 129Xe MRI","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2013-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1},{"nctId":"NCT01833390","phase":"PHASE2","title":"MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects","status":"COMPLETED","sponsor":"Xemed LLC","startDate":"2011-09","conditions":"Asthma, COPD, Healthy","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["129Xe"],"phase":"marketed","status":"active","brandName":"Hyperpolarized xenon","genericName":"Hyperpolarized xenon","companyName":"Oxford University Hospitals NHS Trust","companyId":"oxford-university-hospitals-nhs-trust","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hyperpolarized xenon is inhaled as a contrast agent that enhances magnetic resonance imaging (MRI) by providing increased signal in lung tissue due to its nuclear spin polarization. Used for Pulmonary ventilation imaging in patients with chronic obstructive pulmonary disease (COPD), Assessment of regional lung function and gas exchange abnormalities.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}